Press release
Global Advanced Drug Delivery CDMO Market Size, Share, Trends & Growth Analysis Report 2027 - Evonik Health, SHL Medical, Lubrizol Life Science, Acino International, Pharmathen
Multiple Advantages Offered by Advanced Drug Delivery Systems Fuels the Demand of Advanced Drug Delivery CDMO Market
Advanced drug delivery systems have emerged as an easy and accurate method of delivering the drug to a specific site. These systems offer many benefits over the traditional systems such as targeted and controlled release of new molecules to sites, consistent absorption of the drug, no requirement of frequent dosing, reduced variability in systemic drug concentrations, and reduction in toxic metabolites. Advanced drug delivery systems optimize drug performance and help deliver superior results, which in turn lead has led to an increased demand for advanced drug delivery CDMOs.
"Advanced drug delivery CDMOs will play an important role in advancing the science of drug delivery. The advanced drug delivery technologies will make medicines that are easier to use, and require less frequent dosing, which in turn will enable patients to spend less time managing their disease."-Senior Scientist, Advanced Drug Delivery CDMO, USA
Private Equity Companies & Investments in Advanced Drug Delivery CDMOs Triggers the Advanced Drug Delivery CDMO Market Growth
Citing the potential growth prospects of the advanced drug delivery systems market, many private equity companies & investors have invested in the advanced drug delivery CDMO market.
For instance,
In December 2022, EQT Future and ATHOS, alongside other co-investors, invested in SHL Medical, a leading provider of advanced drug delivery solutions.
In September 2021, ADQ, an Abu Dhabi-based holding company acquired Acino, a leader in advanced drug delivery systems. Through the investment, ADQ intends to develop an integrated pharma platform including advanced drug development, in-licensing, manufacturing, and commercialization capabilities in select growth-leading markets.
Competitive Landscape Analysis: Advanced Drug Delivery CDMO Market
Some of the leading players operating in the global advanced drug delivery CDMO market are Evonik Health Care, SHL Medical, Lubrizol Life Science, Acino International AG, Pharmathen, Phillips-Medisize.
Efficient Growth Strategies Adopted by the Global Market Players to Establish Their Foothold in the Global Advanced Drug Delivery CDMO Market
Global players operating in the global advanced drug delivery CDMO market are adopting aggressive growth strategies such as taking over related firms, launching new products and entering into mergers & collaborations to garner a larger market share.
For instance,
In July 2023, SHL Medical, a leading provider of advanced drug delivery solutions acquired LCA Automation, a Swiss innovative automation solutions provider. The acquisition of LCA Automation is aligned with SHL Medical's strategy to cater to the growing market demand for drug delivery solutions, expand its global presence, and strengthen its vertical capabilities globally
The global advanced drug delivery CDMO market is projected a witness a healthy growth in the coming years due to positive investments by private equity companies and investors, growing adoption of controlled-release drug delivery systems by patient populations, and aggressive organic and inorganic growth strategies followed by the global industry players.
Get An In-Depth Analysis on Advanced Drug Delivery CDMO Market with a FREE Sample Report @ https://meditechinsights.com/advanced-drug-delivery-cdmo-market/
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Advanced Drug Delivery CDMO Market Size, Share, Trends & Growth Analysis Report 2027 - Evonik Health, SHL Medical, Lubrizol Life Science, Acino International, Pharmathen here
News-ID: 3207008 • Views: …
More Releases from Medi-Tech Insights
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
